Clinical Study
The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
Table 1
Baseline characteristics of the study populations.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are given as proportions or medians (25, 75 percentiles). ACE-I: angiotensin-converting enzyme inhibitor. AII antagonist: angiotensin II receptor antagonist. β blocker: beta adrenergic receptor blocker. ACB: coronary bypass surgery. DBP: diastolic blood pressure. EF: ejection fraction. PCI: percutaneous coronary intervention. SBP: systolic blood pressure. TnT: Troponin T. |